Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-171-8 | CAS number: 64742-67-2 A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1984-09-25 to 1984-10-09
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study is classified as reliable without restriction because it was carried out according to or similar to OECD Guideline 401.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
Test material
- Reference substance name:
- Hydrotreated light naphthenic oil, insufficiently refined, IP 346 ≥ 3% (CAS # 64742-53-6)
- IUPAC Name:
- Hydrotreated light naphthenic oil, insufficiently refined, IP 346 ≥ 3% (CAS # 64742-53-6)
- Details on test material:
- Read Across to Lubricant Base Oils
- Test substance: API 83-12 (CAS No. 64742-53-6)
- Name of test material (as cited in study report): API 83-12
- Substance Type: Lubricant Base Oils (IP 346 ≥ 3%)
- Molecular weight (if other than submission substance): 148.3
- Physical state: clear, colorless liquid
- Composition of test material, percentage of components: 61.6% saturates, 36.1% aromatics, 2.3% polar compounds
- Viscosity: 53.5 SSU at 100°F, 33.3 SSU at 210°F
- Sulphur, Wt%: 0.019
- Gravity API: 26.2
- Flash Point 255°F
- Distillation at 10% 533, at 95% 713 °F
- Initial Boiling Point: 464°F
- End Point 796 °F
- Pour Point 60°F
- Colour 0.5
- Aniline 148.3 °F
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Stone Ridge, New York
- Age at study initiation: approximately 7 weeks
- Weight at study initiation: between 295 and 349 grams for males; between 231 and 248 grams for females
- Fasting period before study: overnight prior to testing
- Housing: group cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24°C
- Humidity (%): 54% to 64% relative humidity
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES: From: 1984-09-25 To: 1984-10-09
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 5.62 ml/kg bw based upon average bulk density of 0.89 g/mL
- Doses:
- 5000 mg/kg fasted body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observed for clinical signs and mortality at hourly intervals for 6 hours after test article administration; observed twice daily thereafter for 14 days for clinical signs and mortality; body weights were taken before fasting, just prior to test material administration, and at 7 and 14 days following administration of test material
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, gross necropsy examination - Statistics:
- No statistics were performed in the study.
Results and discussion
- Preliminary study:
- Not applicable.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: see Other findings below
- Gross pathology:
- One female had a spleen that was cystic, mottled red and tan, and rough surface. The animal's pancreas adhered to the entire surface of the spleen. All other animals had no visible lesions upon gross examination.
- Other findings:
- Clinical signs seen during the study included hypoactivity, yellow-stained anal area, hair loss in urogenital region, and swollen hind paws. All animals had returned to normal by day 3 with the following exceptions: one male rat and two female rats exhibited hair loss in the urogenital region on days 6 and 7. This abnormality continued in one male and female rat through day 10. One female rat exhibitedhypoactivity on days 6 and 7. One female rat
exhibited swollen hind paws on day 7,and from day 10 through study termination.
Body weight:
No data reported
Any other information on results incl. tables
There
were no deaths during the study.
Clinical signs observed included: hypoactivity, yellow-stained anal area,
hair
loss in the urogenital region and swollen hind paws.
All animals returned to normal by day 3 and had gained weight by day 7.
At necropsy, there were no visible lesions except in one female in which the
spleen was cystic, mottled red and tan and had a rough surface. In
this
animal the pancreas adhered to the entire surface of the spleen.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for rats is greater than 5000 mg/kg bw when administered by gavage.
- Executive summary:
Read across justification
The physical and chemical properties of foots oils are comparable to the other lubricant base oil intermediate streams from which they are derived. Hence their health effects are also similar to those of other lubricant base oils, and the conclusions of the hazard assessment for other lubricant base oils also apply to foots oils.
In an acute oral toxicity study, Sprague-Dawley rats (5/sex) were administered a single oral gavage of API 83-12 at a dose level of 5000 mg/kg and observed for 14 days. No mortalities were observed and clinical signs included hypoactivity, yellow-stained anal area, hair loss in the urogenital region and swollen hind paws. All animals returned to normal by day 3 and gained weight by day 7. At gross necropsy, one female animal had aspleen which was cystic, mottled red and tan and had a rough surface. In this animal, the pancreas adhered to the entire surface of the spleen. All other animals were free of visible lesions. The oral LD50 was determined to be greater than 5000 mg/kg in both males and females.
This study received a Klimisch score of 1 and is classified as reliable without restriction because it was carried out in accordance with OECD Guideline 401.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.